BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31303415)

  • 1. Differences Between Patients With Idiopathic Pleuroparenchymal Fibroelastosis and Those With Other Types of Idiopathic Interstitial Pneumonia in Candidates for Lung Transplants.
    Shiiya H; Tian D; Sato M; Karasaki T; Kitano K; Nagayama K; Anraku M; Kaga K; Matsui Y; Nakajima J
    Transplant Proc; 2019; 51(6):2014-2021. PubMed ID: 31303415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.
    Shiiya H; Nakajima J; Date H; Chen-Yoshikawa TF; Tanizawa K; Handa T; Oto T; Otani S; Shiotani T; Okada Y; Matsuda Y; Shiraishi T; Moroga T; Minami M; Funaki S; Chida M; Yoshino I; Hatachi G; Uemura Y; Sato M
    Surg Today; 2021 Aug; 51(8):1276-1284. PubMed ID: 33576927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis.
    Kato M; Sasaki S; Kurokawa K; Nakamura T; Yamada T; Sasano H; Arano N; Komura M; Ihara H; Nagashima O; Shiota S; Takahashi F; Takahashi K
    Respiration; 2019; 97(4):319-328. PubMed ID: 30522096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hypothyroidism in idiopathic pleuroparenchymal fibroelastosis a novel lung-thyroid syndrome?
    Awano N; Izumo T; Fukuda K; Tone M; Yamada D; Takemura T; Ikushima S; Kumasaka T
    Respir Investig; 2018 Jan; 56(1):48-56. PubMed ID: 29325681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
    Suzuki Y; Fujisawa T; Sumikawa H; Tanaka T; Sugimoto C; Kono M; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2020 Sep; 171():106078. PubMed ID: 32917352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
    Yamagata A; Arita M; Tachibana H; Tokioka F; Sugimoto C; Sumikawa H; Tanaka T; Yasui H; Fujisawa T; Nakamura Y; Suda T; Ishida T
    Respir Res; 2021 Apr; 22(1):115. PubMed ID: 33879137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ishii H; Nabeshima K; Watanabe K
    Histol Histopathol; 2021 Mar; 36(3):291-303. PubMed ID: 33315234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
    Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H
    Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ishii H; Kushima H; Johkoh T; Yabuuchi H; Fujita M; Nabeshima K; Watanabe K
    Sci Rep; 2020 Jan; 10(1):306. PubMed ID: 31941942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum latent transforming growth factor-β binding protein 4 as a novel biomarker for idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ikeda T; Kushima H; Fujita M; Nakamura T; Nabeshima K; Ishii H
    Respir Med; 2020 Sep; 171():106077. PubMed ID: 32658840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
    Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.
    Hayashi H; Nei T; Abe S; Saito Y; Kokuho N; Atsumi K; Fujita K; Saito T; Tanaka T; Gemma A; Azuma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):35-40. PubMed ID: 32476820
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic pleuroparenchymal fibroelastosis, a new idiopathic interstitial pneumonia: A case report.
    Hurtado EJ; González ML; Soto Mdel M; Rueda FJ; Nadal FJ; Cantero AR
    Chron Respir Dis; 2016 Aug; 13(3):312-6. PubMed ID: 26810762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
    Tanizawa K; Handa T; Kubo T; Chen-Yoshikawa TF; Aoyama A; Motoyama H; Hijiya K; Yoshizawa A; Oshima Y; Ikezoe K; Tokuda S; Nakatsuka Y; Murase Y; Nagai S; Muro S; Oga T; Chin K; Hirai T; Date H
    Respir Res; 2018 Aug; 19(1):162. PubMed ID: 30165854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
    Suzuki Y; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    Sci Rep; 2018 Sep; 8(1):14074. PubMed ID: 30232390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
    Watanabe K; Ishii H; Kiyomi F; Terasaki Y; Hebisawa A; Kawabata Y; Johkoh T; Sakai F; Kondoh Y; Inoue Y; Azuma A; Suda T; Ogura T; Inase N; Homma S;
    Respir Investig; 2019 Jul; 57(4):312-320. PubMed ID: 30981683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.
    Ishii H; Kinoshita Y; Kushima H; Nagata N; Watanabe K
    Chron Respir Dis; 2019; 16():1479973119867945. PubMed ID: 31387379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of prognostic factors and the effect of anti-fibrotic therapy on waitlist mortality in lung transplant candidates with idiopathic interstitial pneumonias.
    Miyahara S; Waseda R; Tokuishi K; Sato T; Iwasaki A; Shiraishi T
    Respir Investig; 2021 Jul; 59(4):428-435. PubMed ID: 33888448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.
    Kono M; Tsunoda T; Ikeda S; Yagi S; Hirama R; Watanuki M; Oshima Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Investig; 2023 Mar; 61(2):210-219. PubMed ID: 36773509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.